PriscillaYingHsueMD

Cardiology • Los Angeles, CA

Adult Congenital Heart Disease

Associate Professor, Medicine, University of California, San Francisco, School of Medicine

Join to view full profile

Dr. Hsue is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hsue's full profile

Already have an account?

Office
100 Medical Plaza Driveway Suite 630
Los Angeles, CA 90095
Phone+1 310-825-9011

Fax+1 415-206-3872

Education & Training

University of California (San Francisco)Fellowship, Cardiovascular Disease, 1999 - 2002
University of California (San Francisco)Residency, Internal Medicine, 1996 - 1999
University of California San Francisco School of MedicineClass of 1996

Certifications & Licensure

CA State Medical License 1998 - 2026
American Board of Internal Medicine Cardiovascular Disease

Clinical Trials

Effect of Raltegravir on Endothelial Function in HIV-Infected Patients Start of enrollment: 2009 Jan 01
Completed
Phase 4
Effect of Maraviroc on Endothelial Function in HIV-Infected Patients Start of enrollment: 2010 Jan 01
Completed
Phase 3
Atherosclerosis in Rheumatoid Arthritis Start of enrollment: 2009 Sep 01
Completed
The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk Start of enrollment: 2010 Apr 01
Completed
Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors Start of enrollment: 2011 Sep 01
Terminated
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection Start of enrollment: 2003 Jul 01
Completed
Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease Start of enrollment: 2013 Jul 01
Completed
Phase 4
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications Start of enrollment: 2014 Jan 31
Completed
Phase 2
Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients Start of enrollment: 2020 Jun 09
Completed
Phase 2
Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial Start of enrollment: 2022 Jul 01
Withdrawn
Phase 1, Phase 2
Roles: Contact, Sponsor-Investigator, Principal Investigator
REVERSE-Long COVID-19 With Baricitinib Study Start of enrollment: 2024 Oct 21
WITHDRAWN
PHASE3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: rationale and protocol for the COMBO-H...
Colette DeJong, Matthew S Durstenfeld, Jonathan D Davis, Christina S Wang, Elise D Riley
BMJ Open. 2025-03-21
Multicenter study of heart failure phenotypes and physician-adjudicated etiologies in people with HIV.
Nour Beydoun, Robin M Nance, Matthew S Durstenfeld, Alexander P Hoffmann, Bridget M Whitney
AIDS. 2025-03-18
Direct-to-Physician Marketing and Uptake of Optimal Medical Therapy for Heart Failure With Reduced Ejection Fraction.
Colette DeJong, Kosuke Inoue, Matthew S Durstenfeld, Anubha Agarwal, Justin C Chen
JACC. Heart Failure. 2025-03-12

Journal Articles

Association of Viral Persistence and Atherosclerosis in Adults with Treated HIV Infection
Jeffrey N Martin, Steven G Deeks, Priscilla Y Hsue, JAMA Network Open
Inflammation, Immunity, and Infection in Atherothrombosis
Paul M Ridker, Valentin Fuster, Priscilla Y Hsue, Peter Libby, ScienceDirect
Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Grou...
Steven G Deeks, James H Stein, Carl Fichtenbaum, Judith S Currier, Priscilla Y Hsue, Eric S Daar, Ahmed Tawakol, Michael Lederman, Tanvir Bell, Diane Havlir, Clinical Infectious Diseases

Press Mentions

Injectable Medications Prove Effective at Lowering LDL CholesterolJanuary 17th, 2025
Chinese American Immigrants Face Higher Risk of Cardiovascular Disease Depending on Length of Residence and Location in the U.S.September 5th, 2024
How Prolonged COVID-19 Influences Physical PerformanceOctober 21st, 2022
Join now to see all

Grant Support

Heart and Lung Outcomes Post-TB (HALO Post-TB)UNIVERSITY OF CALIFORNIA LOS ANGELES2024–2029
REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRDVANDERBILT UNIVERSITY MEDICAL CENTER2024–2028
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
Cholesterol and inflammation Lowering via BEmpedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)UNIVERSITY OF CALIFORNIA LOS ANGELES2022–2027
In Vivo PET Imaging of HIV InfectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2026
Role of Hematopoietic System and Proteomics in HIV-Associated CardiovascularDiseaseUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2025
Cell-Type Specific Mechanisms of HIV CardiomyopathyUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2025
Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV InfectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV InfectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
Inflammation, Viral Replication, And Atherosclerosis In Treated HIV InfectionNational Heart, Lung, And Blood Institute2008–2011
Epidemiology And Pathogenesis Of Pulmonary Hypertension In HIV PatientsNational Heart, Lung, And Blood Institute2007–2011
Pathogenesis Of Atherosclerosis In HIV Patients On HaartNational Institute Of Allergy And Infectious Diseases2005–2009
Immunologic And Inflammatory Factors In Patients With HIVNational Center For Research Resources2005
HHV-8 And Pulmonary Arterial Pressures In Patients With HIV InfectionNational Center For Research Resources2005